Michele Navarra

Overview

Best Publications

• Effect of Acetaldehyde Intoxication and Withdrawal on NPY Expression: Focus on Endocannabinoidergic System Involvement

  Fulvio Plescia;Anna Brancato;Rosa Anna Maria Marino;Carlotta Vita

  261
  Citations

• Passiflora incarnata L.: Ethnopharmacology, clinical application, safety and evaluation of clinical trials☆

  M. Miroddi;G. Calapai;M. Navarra;P.L. Minciullo

  192
  Citations

• Anticancer activity of liposomal bergamot essential oil (BEO) on human neuroblastoma cells

  Christian Celia;Elena Trapasso;Marcello Locatelli;Michele Navarra

  170
  Citations

• Oxidative stress in benign prostatic hyperplasia: a systematic review.

  Paola Lucia Minciullo;Antonino Inferrera;Michele Navarra;Gioacchino Calapai

  161
  Citations

• gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors.

  M V Catani;M T Corasaniti;M Navarra;G Nisticò

  142
  Citations

• Flavonoid fraction of Bergamot juice reduces LPS-induced inflammatory response through SIRT1-mediated NF-κB inhibition in THP-1 monocytes.

  Roberto Risitano;Monica Currò;Santa Cirmi;Nadia Ferlazzo

  133
  Citations

• The anti-inflammatory and antioxidant effects of bergamot juice extract (BJe) in an experimental model of inflammatory bowel disease.

  Daniela Impellizzeri;Giuseppe Bruschetta;Rosanna Di Paola;Akbar Ahmad

  133
  Citations

• Cell signaling pathways in the mechanisms of neuroprotection afforded by bergamot essential oil against NMDA-induced cell death in vitro.

  M T Corasaniti;M T Corasaniti;J Maiuolo;S Maida;V Fratto

  120
  Citations

• Neurodegenerative Diseases: Might Citrus Flavonoids Play a Protective Role?

  Santa Cirmi;Nadia Ferlazzo;Giovanni E Lombardo;Elvira Ventura-Spagnolo

  117
  Citations

• The Second Life of Citrus Fruit Waste: A Valuable Source of Bioactive Compounds

  Caterina Russo;Alessandro Maugeri;Giovanni Enrico Lombardo;Laura Musumeci

  112
  Citations

• Montelukast-Induced Adverse Drug Reactions: A Review of Case Reports in the Literature

  Gioacchino Calapai;Marco Casciaro;Marco Miroddi;Fabrizio Calapai

  111
  Citations

• Cardiovascular Toxicity of Tyrosine Kinase Inhibitors Used in Chronic Myeloid Leukemia: An Analysis of the FDA Adverse Event Reporting System Database (FAERS)

  Santa Cirmi;Santa Cirmi;Asmae El Abd;Louis Letinier;Michele Navarra

  106
  Citations

• Systematic review of clinical trials assessing pharmacological properties of Salvia species on memory, cognitive impairment and Alzheimer's disease.

  Marco Miroddi;Michele Navarra;Maria C. Quattropani;Fabrizio Calapai

  103
  Citations

• Antiinflammatory activity of glucomoringin isothiocyanate in a mouse model of experimental autoimmune encephalomyelitis

  Maria Galuppo;Sabrina Giacoppo;Gina Rosalinda De Nicola;Renato Iori

  102
  Citations

• Neurological Aspects of Medical Use of Cannabidiol.

  Carmen Mannucci;Michele Navarra;Fabrizio Calapai;Elvira V Spagnolo

  100
  Citations

• Chemopreventive Agents and Inhibitors of Cancer Hallmarks: May Citrus Offer New Perspectives?

  Santa Cirmi;Nadia Ferlazzo;Giovanni E. Lombardo;Alessandro Maugeri

  100
  Citations

• Anticancer Potential of Citrus Juices and Their Extracts: A Systematic Review of Both Preclinical and Clinical Studies

  Santa Cirmi;Alessandro Maugeri;Nadia Ferlazzo;Sebastiano Gangemi

  99
  Citations

• The Immune Inhibitory Receptor LAIR-1 Is Highly Expressed by Plasmacytoid Dendritic Cells and Acts Complementary with NKp44 to Control IFNα Production

  Irene Bonaccorsi;Claudia Cantoni;Claudia Cantoni;Paolo Carrega;Daniela Oliveri

  92
  Citations

• A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury

  Irene Paterniti;Daniela Impellizzeri;Rosanna Di Paola;Michele Navarra

  91
  Citations

• IL-33/IL-31 Axis: A Potential Inflammatory Pathway

  Eleonora Di Salvo;Elvira Ventura-Spagnolo;Marco Casciaro;Michele Navarra

  88
  Citations